Literature DB >> 18584938

Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV).

Marija L Mihajlovic1, Petar M Mitrasinovic.   

Abstract

In the context of a recent pandemic threat by the worldwide spread of H5N1 avian influenza, the high resistance of H5N1 virus to the most widely used commercial drug, oseltamivir (Tamiflu), is currently an important research topic. Herein, molecular bases of the mechanism of H5N1 NA resistance to oseltamivir were elucidated using a computational approach in a systematic fashion. Using the crystal structure of the complex of H5N1 NA with OTV (PDB ID: 2hu0) as the starting point, the question, how mutations at His274 by both smaller side chain (Gly, Ser, Asn, Gln) and larger side chain (Phe, Tyr) residues influence the sensitivity of N1 to oseltamivir, was addressed and correlated with the experimental data. The smaller side chain residue mutations of His274 resulted in slightly enhanced or unchanged NA sensitivity to OTV, while His274Phe and His274Tyr reduced the susceptibility of OTV to N1. In contrast to the binding free energies, the net charges of Glu276 and Arg224, making charge-charge interactions with Glu276, were established to be more sensitive to detecting subtle conformational differences induced at the key residue Glu276 by the His274X mutations. This study provides deeper insights into the possibility of developing viable drug-resistant mutants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18584938     DOI: 10.1016/j.bpc.2008.06.003

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  2 in total

1.  Evaluation of a Set of C9 N-acyl Neu5Ac2en Mimetics as Viral Sialidase Selective Inhibitors.

Authors:  Sadagopan Magesh; Nongluk Sriwilaijaroen; Setsuko Moriya; Hiromune Ando; Taeko Miyagi; Yasuo Suzuki; Hideharu Ishida; Makoto Kiso
Journal:  Int J Med Chem       Date:  2010-12-08

2.  Why are oseltamivir and zanamivir effective against the newly emerged influenza A virus (A/H1N1)?

Authors:  Kunqian Yu; Cheng Luo; Guangrong Qin; Zhijian Xu; Ning Li; Hong Liu; Xu Shen; Jianpeng Ma; Qinghua Wang; Caiguang Yang; Weiliang Zhu; Hualiang Jiang
Journal:  Cell Res       Date:  2009-09-22       Impact factor: 25.617

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.